RU2008140688A - Иммуносупрессивный пептид - Google Patents
Иммуносупрессивный пептид Download PDFInfo
- Publication number
- RU2008140688A RU2008140688A RU2008140688/04A RU2008140688A RU2008140688A RU 2008140688 A RU2008140688 A RU 2008140688A RU 2008140688/04 A RU2008140688/04 A RU 2008140688/04A RU 2008140688 A RU2008140688 A RU 2008140688A RU 2008140688 A RU2008140688 A RU 2008140688A
- Authority
- RU
- Russia
- Prior art keywords
- formula
- immunosuppressive
- amino acid
- simian
- immunosuppressive peptide
- Prior art date
Links
- 230000001506 immunosuppresive effect Effects 0.000 title claims abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 6
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 claims abstract 2
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 claims abstract 2
- 241000713821 Mason-Pfizer monkey virus Species 0.000 claims abstract 2
- 108010067902 Peptide Library Proteins 0.000 claims abstract 2
- 241000714229 Simian retrovirus 1 Species 0.000 claims abstract 2
- 241001529481 Simian retrovirus 2 Species 0.000 claims abstract 2
- 241000713820 Squirrel monkey retrovirus Species 0.000 claims abstract 2
- 125000000539 amino acid group Chemical group 0.000 claims abstract 2
- 238000006467 substitution reaction Methods 0.000 claims abstract 2
- 241001430294 unidentified retrovirus Species 0.000 claims abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Иммуносупрессивный пептид формулы с вариабельными позициями, отличающийся тем, что формула с двумя (X) или тремя (Y) аминокислотными заменами ! ! X1={G,A} ! X2={L,M} ! Х3={Е,А} ! X4={F,A} ! Х5={Е,К} ! X6={F,Y} ! X7={Y,W} ! Y1={K,R,Q} ! Y2={L,I,T} ! Y3={L,I,T} ! Y4={G,D,N} ! Y5={V,L,T} ! Y6={I,L,K}. ! 2. Иммуносупрессивный пептид по п.1, отличающийся тем, что для экзогенных ретровирусов типа С и D (Human T-cell leukemia virus type I/II, Simian Mason-Pfizer virus, Simian retrovirus SRV-1/2, Squirrel monkey retrovirus) формула ! ! X1={F,T} ! X2={W,A} ! X3={L,I} ! X4={L,K} ! X5={L,I} ! X6={Q,K} ! X7={L,Y} !X8={A,-} ! X9={I,K} ! X10={N,G} ! X11={I,T,S} ! X12={V,H}. ! 3. Иммуносупрессивный пептид по п.1, отличающийся тем, что пептидная библиотека ! ! где # - обозначает совпадающие аминокислотные остатки.
Claims (3)
2. Иммуносупрессивный пептид по п.1, отличающийся тем, что для экзогенных ретровирусов типа С и D (Human T-cell leukemia virus type I/II, Simian Mason-Pfizer virus, Simian retrovirus SRV-1/2, Squirrel monkey retrovirus) формула
X1={F,T}
X2={W,A}
X3={L,I}
X4={L,K}
X5={L,I}
X6={Q,K}
X7={L,Y}
X8={A,-}
X9={I,K}
X10={N,G}
X11={I,T,S}
X12={V,H}.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008140688/04A RU2008140688A (ru) | 2008-10-15 | 2008-10-15 | Иммуносупрессивный пептид |
PCT/RU2008/000682 WO2010044691A1 (ru) | 2008-10-15 | 2008-11-01 | Иммуносупрессивный пептид |
US13/124,540 US20120004394A1 (en) | 2008-10-15 | 2008-11-01 | Immunosuppressive peptide |
EP08877453A EP2351771A4 (en) | 2008-10-15 | 2008-11-01 | IMMUNOSUPPRESSIVE PEPTIDE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008140688/04A RU2008140688A (ru) | 2008-10-15 | 2008-10-15 | Иммуносупрессивный пептид |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2008140688A true RU2008140688A (ru) | 2010-04-20 |
Family
ID=42106699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008140688/04A RU2008140688A (ru) | 2008-10-15 | 2008-10-15 | Иммуносупрессивный пептид |
Country Status (4)
Country | Link |
---|---|
US (1) | US20120004394A1 (ru) |
EP (1) | EP2351771A4 (ru) |
RU (1) | RU2008140688A (ru) |
WO (1) | WO2010044691A1 (ru) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643714A (en) * | 1986-12-31 | 1997-07-01 | Genelabs Technologies, Inc. | Method and assay for HTLV |
IL120561A0 (en) * | 1996-04-24 | 1997-07-13 | Akzo Nobel Nv | Peptides suitable for use in immunosuppressive therapy |
RU2123859C1 (ru) * | 1996-05-06 | 1998-12-27 | Закрытое акционерное общество Центр "Пептос" | Пептид, обладающий иммуносупрессивным свойством |
TW200409815A (en) * | 2002-12-12 | 2004-06-16 | Dev Center Biotechnology | Human T-lymphotrophic virus (HTLV) fusion protein, nucleic acid and vector encoding the protein, and kit for testing human T-lymphotrophic virus using the protein |
CA2561376C (en) * | 2004-03-30 | 2016-06-21 | Institut Gustave Roussy | Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
-
2008
- 2008-10-15 RU RU2008140688/04A patent/RU2008140688A/ru unknown
- 2008-11-01 US US13/124,540 patent/US20120004394A1/en not_active Abandoned
- 2008-11-01 WO PCT/RU2008/000682 patent/WO2010044691A1/ru active Application Filing
- 2008-11-01 EP EP08877453A patent/EP2351771A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2010044691A1 (ru) | 2010-04-22 |
EP2351771A1 (en) | 2011-08-03 |
US20120004394A1 (en) | 2012-01-05 |
EP2351771A4 (en) | 2012-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31666B1 (fr) | Cyclic peptide cxcr4 antagonists | |
CY1113288T1 (el) | Ανασυνδυασμενοι φορεις που βασιζονται επι του τροποποιημενου ιου αγκυρας (mva) ως αποτρεπτικα και θεραπευτικα εμβολια εναντι aids | |
EA201070271A1 (ru) | Пептиды для получения вакцины | |
EA200200724A1 (ru) | Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич) | |
WO2008118849A3 (en) | Hiv-1 protease inhibitors | |
ATE445411T1 (de) | Mva-exprimierende modifizierte hiv-envelope-, gag-und pol-gene | |
WO2007013047A3 (en) | Water-dispersible anti-retroviral pharmaceutical compositions | |
SG178909A1 (en) | Generation of a broad t-cell response in humans against hiv | |
EA201101397A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
EP2567967A3 (en) | Method of using adenoviral vectors to induce an immune response | |
EA201892233A1 (ru) | Композиции и способы, связанные с иммуногенами вич-1 | |
NO20014841L (no) | Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet | |
RU2008140688A (ru) | Иммуносупрессивный пептид | |
WO2018057967A3 (en) | Constructs targeting hiv peptide/mhc complexes and uses thereof | |
WO2010041241A3 (en) | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding | |
WO2011091319A3 (en) | Dendritic cell vaccines | |
WO2007002172A3 (en) | Hiv-1 protease inhibitors | |
WO2007018550A3 (en) | Compositions and methods for the detection of hiv-1/hiv-2 infection | |
EA200500533A1 (ru) | Пептидные производные - ингибиторы слияния при вич-инфекции | |
EP2632942A4 (en) | RECOMBINANT ENVELOPE PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND VACCINE CONTAINING THE SAME | |
ES2549209B1 (es) | Partículas víricas VSV-VIH que carecen de la funcionalidad transcriptasa inversa y aplicaciones terapéuticas de las mismas | |
CR9859A (es) | Inhibidores de la enzima integrasa de vih | |
WO2010135663A3 (en) | Compositions and methods for the detection of hiv-1/hiv-2 infection | |
TH82347B (th) | วัคซีนเชื้อไวรัสทางภูมิคุ้มกันบกพร่องของมนุษย์ | |
TH82347A (th) | วัคซีนเชื้อไวรัสทางภูมิคุ้มกันบกพร่องของมนุษย์ |